Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Revenue (Gross)
Ratios

Serina Therapeutics (SER) Accumulated Depreciation & Amortization (2017 - 2025)

Serina Therapeutics' Accumulated Depreciation & Amortization history spans 6 years, with the latest figure at $601000.0 for Q4 2024.

  • For Q4 2024, Accumulated Depreciation & Amortization rose 54.1% year-over-year to $601000.0; the TTM value through Dec 2024 reached $601000.0, up 54.1%, while the annual FY2024 figure was $601000.0, 54.1% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2024 was $601000.0 at Serina Therapeutics, up from $390000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $699000.0 in Q4 2020 and bottomed at $227000.0 in Q1 2020.
  • The 4-year median for Accumulated Depreciation & Amortization is $390000.0 (2023), against an average of $404285.7.
  • The largest annual shift saw Accumulated Depreciation & Amortization soared 2170.0% in 2020 before it changed 0.0% in 2021.
  • A 4-year view of Accumulated Depreciation & Amortization shows it stood at $699000.0 in 2020, then crashed by 67.53% to $227000.0 in 2021, then surged by 71.81% to $390000.0 in 2023, then soared by 54.1% to $601000.0 in 2024.
  • Per Business Quant, the three most recent readings for SER's Accumulated Depreciation & Amortization are $601000.0 (Q4 2024), $390000.0 (Q4 2023), and $227000.0 (Q1 2021).